ReachMD pubblico
[search 0]
Altro

Scarica l'app!

show episodes
 
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
 
Loading …
show series
 
CME credits: 0.25 Valid until: 01-02-2024 Claim your CME credit at https://reachmd.com/programs/cme/titrating-and-dosing-device-therapy-for-dre-best-practices-for-optimizing-patient-outcomes/14854/ Vagus nerve stimulation (VNS) therapy is an add-on neuromodulation treatment designed for adults and children diagnosed with drug-resistant epilepsy (DR…
 
CME credits: 0.50 Valid until: 31-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/case-management-strategies-for-patients-with-adpkd-part-2/13880/ This Expert Exchange webcast is designed to help improve clinicians’ ability to apply pharmacologic and non-pharmacologic strategies in the management of patients with ADPKD.…
 
CME credits: 0.50 Valid until: 31-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/closing-the-gap-to-care-assessing-cad-and-improving-patient-outcomes-with-revascularization/14855/ Less than 20% of patients admitted to the hospital with new-onset heart failure are assessed for coronary artery disease (CAD) even though revasculariz…
 
CME credits: 0.50 Valid until: 30-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/predicting-type-1-diabetes-using-genetic-testing-or-islet-antibody-screening-are-we-there-yet/14286/ Autoantibody Screening to Identify Risk for Type 1 Diabetes T1D defines a continuum that begins during an asymptomatic prodrome before the disease ma…
 
CME credits: 0.50 Valid until: 26-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/updates-in-glomerular-disease/14891/ Patients with chronic kidney disease often have a multitude of comorbidities which may present challenges in diagnosis, treatment, and management. In addition, the limitations of currently available treatments may…
 
CME credits: 0.50 Valid until: 24-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/case-management-strategies-for-patients-with-adpkd-part-1/13879/ This Expert Exchange webcast is designed to help improve clinicians’ ability to apply pharmacologic and non-pharmacologic strategies in the management of patients with ADPKD.…
 
CME credits: 0.25 Valid until: 17-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/improving-meibomian-gland-dysfunction-with-device-management/14810/ How can more advanced measures improve meibomian gland function to relieve dry eye symptoms and improve refraction? Listen as Dr. Cynthia Matossian and Dr. Jillian Ziemanski discuss …
 
CME credits: 0.25 Valid until: 16-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/treatment-options-for-invasive-fungal-infections-why-they-dont-always-work/14809/ The changing epidemiology of invasive fungal infections, ongoing antifungal resistance, drug-drug interactions, and few oral agents leave patients with limited viable t…
 
CME credits: 0.50 Valid until: 16-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/is-the-weight-over-next-generation-of-anti-obesity-therapeutics/14590/ Obesity affects 600 million people globally and over one third of the American population. Along with associated comorbidities, including cardiovascular disease, stroke, diabetes,…
 
CME credits: 0.25 Valid until: 10-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/invasive-fungal-infections-more-common-than-you-think/14808/ Despite advances in diagnosis and treatment, as well as the dissemination of clinical practice guidelines, both the threat and burden of invasive fungal infections are increasing and undera…
 
CME credits: 0.50 Valid until: 10-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/testing-and-screening-for-type-1-diabetes-t1d-genes-antigens-autoantibodies-methodology-and-clinical-utility/14285/ Autoantibody Screening to Identify Risk for Type 1 DiabetesT1D defines a continuum that begins during an asymptomatic prodrome before …
 
CME credits: 1.00 Valid until: 10-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/bcma-who-and-when-immunotherapies-in-patients-with-rrmm/14729/ Given the complexity of care for patients with multiple myeloma (MM) and the mounting clinical trial data, it is crucial to stay abreast of investigational agents and new data from curren…
 
CME credits: 1.00 Valid until: 10-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/individualized-approaches-in-cllsll-meeting-the-needs-of-your-patients-now-and-preparing-for-the-future/14730/ The emerging treatment landscape for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) has resulted in improved outco…
 
CME credits: 0.25 Valid until: 06-01-2024 Claim your CME credit at https://reachmd.com/programs/cme/tentative-approval-understanding-the-fda-ruling-on-once-nightly-sodium-oxybate/14688/ While most clinicians are aware of a drug being either “approved” or “not approved” by the FDA, many are not familiar with the term “tentative approval.” Leading ex…
 
CME credits: 0.50 Valid until: 30-12-2023 Claim your CME credit at https://reachmd.com/programs/cme/transforming-cervical-cancer-screening-and-management-new-guidelines-new-tests-a-case-based-discussion/14676/ Experts discuss the ACS and ASCCP CCV screening guidelines and review the benefits of primary screening and the latest data driven testing o…
 
CME credits: 0.25 Valid until: 30-12-2023 Claim your CME credit at https://reachmd.com/programs/cme/talking-rare-epidemiology-and-pathogenesis-of-apol1-mediated-kidney-disease/14781/ End-stage kidney disease (ESKD) is at least 3x higher among African Americans compared to Americans of European descent. Carriers of APOL1 variants with chronic kidney…
 
Loading …

Guida rapida